Effect of pirfenidone on breathlessness in patients with idiopathic pulmonary fibrosis

New post hoc analysis of IPF clinical trials suggests that treatment with pirfenidone slows the worsening of patient-reported breathlessness over 12 months versus placebo in patients with more advanced disease (GAP stage II/III or FVC <80%) http://bit.ly/2yJyUVT

Gardado en:
Detalles Bibliográficos
Publicado en:Eur Respir J
Main Authors: Glassberg, Marilyn K., Wijsenbeek, Marlies S., Gilberg, Frank, Petzinger, Ute, Kirchgaessler, Klaus-Uwe, Albera, Carlo
Formato: Artigo
Idioma:Inglês
Publicado: European Respiratory Society 2019
Assuntos:
Agora
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6766683/
https://ncbi.nlm.nih.gov/pubmed/31164431
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1183/13993003.00399-2019
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares